These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23510067)

  • 1. Gaucher disease and myeloma.
    Ayto R; Hughes DA
    Crit Rev Oncog; 2013; 18(3):247-68. PubMed ID: 23510067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cell lymphoma and myeloma in murine Gaucher's disease.
    Pavlova EV; Wang SZ; Archer J; Dekker N; Aerts JM; Karlsson S; Cox TM
    J Pathol; 2013 Sep; 231(1):88-97. PubMed ID: 23775597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin Abnormalities in Gaucher Disease: an Analysis of 278 Patients Included in the French Gaucher Disease Registry.
    Nguyen Y; Stirnemann J; Lautredoux F; Cador B; Bengherbia M; Yousfi K; Hamroun D; Astudillo L; Billette de Villemeur T; Brassier A; Camou F; Dalbies F; Dobbelaere D; Gaches F; Leguy-Seguin V; Masseau A; Pers YM; Pichard S; Serratrice C; Berger MG; Fantin B; Belmatoug N; On Behalf Of The French Evaluation Of Gaucher Disease Treatment Committee
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32069933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective Sphingolipids Metabolism and Tumor Associated Macrophages as the Possible Links Between Gaucher Disease and Blood Cancer Development.
    Wątek M; Piktel E; Wollny T; Durnaś B; Fiedoruk K; Lech-Marańda E; Bucki R
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of sphingolipids on osteoblast and osteoclast activity in Gaucher disease.
    Reed MC; Schiffer C; Heales S; Mehta AB; Hughes DA
    Mol Genet Metab; 2018 Aug; 124(4):278-286. PubMed ID: 29934064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gaucher disease and multiple myeloma.
    Costello R; O'Callaghan T; Sébahoun G
    Leuk Lymphoma; 2006 Jul; 47(7):1365-8. PubMed ID: 16923570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synchronous multiple myeloma and Gaucher disease.
    Monge J; Chadburn A; Gergis U
    Hematol Oncol Stem Cell Ther; 2020 Mar; 13(1):42-45. PubMed ID: 31622574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry.
    Rosenbloom BE; Cappellini MD; Weinreb NJ; Dragosky M; Revel-Vilk S; Batista JL; Sekulic D; Mistry PK
    Am J Hematol; 2022 Oct; 97(10):1337-1347. PubMed ID: 36054609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gaucher disease: haematological presentations and complications.
    Thomas AS; Mehta A; Hughes DA
    Br J Haematol; 2014 May; 165(4):427-40. PubMed ID: 24588457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Energy balance, glucose and lipid metabolism, cardiovascular risk and liver disease burden in adult patients with type 1 Gaucher disease.
    Nascimbeni F; Dalla Salda A; Carubbi F
    Blood Cells Mol Dis; 2018 Feb; 68():74-80. PubMed ID: 27839982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple myeloma arising from monoclonal gammopathy of undetermined significance in a patient with Gaucher's disease.
    Brady K; Corash L; Bhargava V
    Arch Pathol Lab Med; 1997 Oct; 121(10):1108-11. PubMed ID: 9341594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism.
    Mistry PK; Taddei T; vom Dahl S; Rosenbloom BE
    Crit Rev Oncog; 2013; 18(3):235-46. PubMed ID: 23510066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments.
    Stirnemann J; Belmatoug N; Camou F; Serratrice C; Froissart R; Caillaud C; Levade T; Astudillo L; Serratrice J; Brassier A; Rose C; Billette de Villemeur T; Berger MG
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development.
    Panicker LM; Miller D; Awad O; Bose V; Lun Y; Park TS; Zambidis ET; Sgambato JA; Feldman RA
    Stem Cells; 2014 Sep; 32(9):2338-49. PubMed ID: 24801745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercoagulability, parkinsonism, and Gaucher disease.
    Rosenbaum H; Aharon-Peretz J; Brenner B
    Semin Thromb Hemost; 2013 Nov; 39(8):928-34. PubMed ID: 24129683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gaucher disease and cancer incidence: a study from the Gaucher Registry.
    Rosenbloom BE; Weinreb NJ; Zimran A; Kacena KA; Charrow J; Ward E
    Blood; 2005 Jun; 105(12):4569-72. PubMed ID: 15718419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A patient with Gaucher disease and plasma cell dyscrasia: bidirectional impact.
    Zimran A; Ruchlemer R; Revel-Vilk S
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):389-394. PubMed ID: 33275748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gaucher disease. Unusual presentation and mini-review.
    Rizk TM; Ariganjoye RO; Alsaeed GI
    Neurosciences (Riyadh); 2015 Jul; 20(3):271-6. PubMed ID: 26166597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple myeloma complicating Gaucher's disease.
    West J Med; 1982 Feb; 136(2):122-8. PubMed ID: 7064469
    [No Abstract]   [Full Text] [Related]  

  • 20. Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease.
    Pandey MK; Burrow TA; Rani R; Martin LJ; Witte D; Setchell KD; Mckay MA; Magnusen AF; Zhang W; Liou B; Köhl J; Grabowski GA
    Nature; 2017 Mar; 543(7643):108-112. PubMed ID: 28225753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.